IVIM Health vs He & She MD: Pricing, Protocols, Ratings Compared
The direct verdict: IVIM Health emphasizes third-party satisfaction signals and a proprietary GLP-1 ID protocol with a free month option, while He & She MD bundles clinician messaging, coaching, and progress tracking with lower six-month introductory pricing. For readers deciding fast, choose IVIM for verified reviews and a structured titration protocol; choose He & She MD for built-in coaching and multiple medication formats.
Explore IVIM Health’s free month with code GIFT75
How IVIM Health vs He & She MD differ on price and promos
IVIM advertises a limited offer: Free Month Membership with code GIFT75 and a no-obligation free consultation valued at $75. IVIM lists pricing for compounded semaglutide at $75/mo and tirzepatide at $133/mo alongside a $74.99/mo program fee in some landing details, and FAQ notes the first month starts at $99 with ongoing $174/month. He & She MD presents six-month introductory rates: semaglutide injections from $139/month (intro), oral semaglutide and tirzepatide injections from $199/month (intro), and states those promos renew at higher six-month prices after the first term.
Support model and included services
He & She MD bundles a coaching app with 1:1 clinician messaging, GLP-1 coaching, and progress tracking at no extra cost, and offers free expedited shipping and no membership fee. IVIM positions a clinician-guided GLP-1 ID protocol with weekly dose adjustments and ongoing supervision, emphasizing a structured titration and optimization approach rather than an app-first coaching bundle.
See He & She MD’s coaching app and intro pricing
Regulatory status and medication format
Both providers offer compounded GLP-1 medications and include regulatory disclaimers that compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. He & She MD explicitly lists semaglutide injection, oral semaglutide, and tirzepatide injection formats. IVIM highlights compounded semaglutide and tirzepatide and notes medications are prepared by independent, licensed compounding pharmacies and prescribed after clinician consultation.
Trust signals and outcome claims
IVIM reports a 4.9-star rating on both Google and Trustpilot and cites internal and published observational data claiming faster weight loss for patients following its GLP-1 ID protocol; IVIM clarifies that the 40% faster figure is a proprietary claim and not a head-to-head trial. He & She MD cites retrospective self-reported outcomes and notes named clinical leadership, while warning that headline prices are six-month intro rates that renew higher.
Comparison table: key criteria
| Criteria | IVIM Health | He & She MD |
|---|---|---|
| Intro offers | Free Month Membership with code GIFT75; no‑obligation free consultation ($75 value) | Six-month intro rates: semaglutide from $139/mo, tirzepatide from $199/mo |
| Ongoing pricing | FAQ notes $99 first month, $174/mo ongoing | Intro rates renew higher after six months; renewal examples provided |
| Support model | Clinician-guided GLP-1 ID protocol with weekly adjustments and supervision | App with 1:1 clinician messaging, coaching and progress tracking included |
| Medication formats | Compounded semaglutide and tirzepatide | Semaglutide injection, oral semaglutide, tirzepatide injection |
| Third-party reviews | 4.9 stars on Google and Trustpilot | Named clinical leadership; no dual 4.9-star claim supplied |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications not reviewed by FDA; pharmacies described as USP-compliant, state-regulated |
Pricing clarity and commitment trade-offs
IVIM lowers upfront cost barriers with a free consultation and a free month code, then points to an ongoing clinician program fee and a stated ongoing rate. He & She MD makes support explicit in the base price but structures savings as six-month introductory terms that renew at higher rates; He & She MD notes those promos apply to first six months only.
Check IVIM Health membership details
Safety, claims, and evidence
Both providers include caveats: IVIM states its 40% faster claim is proprietary and not from a head-to-head trial and that compounded medications have not undergone FDA review. He & She MD flags that its outcome figures are self-reported retrospective data and that promo pricing is introductory. Both require clinician consultation and prescription; not all customers will qualify for medication.
Review He & She MD program terms and eligibility
Conclusion: IVIM Health vs He & She MD
In summary, IVIM Health stands out for dual 4.9-star third-party ratings and a proprietary GLP-1 ID protocol plus a free month with code GIFT75; He & She MD stands out for an included coaching app, 1:1 clinician messaging, multiple medication formats, and lower six-month introductory pricing that renews higher. Both use compounded GLP-1 medications and include regulatory disclaimers.
Choose IVIM Health if you prioritize verified external reviews, a clinician-guided GLP-1 ID protocol, and a free month membership with code GIFT75. Choose He & She MD if you want built-in coaching, 1:1 clinician messaging and app tracking bundled with introductory GLP-1 pricing.